suramin has been researched along with fluorouracil in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Hofland, LJ; Lamberts, SW; van Koetsveld, P | 1 |
| Alì, A; Angeli, A; Berruti, A; Dogliotti, L; Paccotti, P; Pia, A | 1 |
| Brunetti, I; Cianci, C; Conte, PF; Danesi, R; Del Tacca, M; Falcone, A; Pfanner, E | 1 |
| Lopez Lopez, R; Peters, GJ; Pinedo, HM; van Rijswijk, RE; Wagstaff, J | 1 |
| Mietz, H | 1 |
| Au, JL; Gan, Y; Song, S; Wientjes, MG | 1 |
| Au, JJ; Bukowski, RM; Cooney, MM; Dreicer, R; Elson, P; Ganapathi, R; George, S; Mekhail, T; Rini, BI; Roman, S; Shen, T; Wientjes, GM | 1 |
2 review(s) available for suramin and fluorouracil
| Article | Year |
|---|---|
Cytotoxic chemotherapy for adrenocortical carcinoma.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bleomycin; Carcinoma; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Resistance, Multiple; Female; Fluorouracil; Gossypol; Humans; Immunologic Factors; Male; Mice; Mice, Nude; Middle Aged; Mitotane; Prospective Studies; Streptozocin; Suramin; Treatment Outcome | 1995 |
[Filtering glaucoma operations. Can growth factor blockers replace antimetabolites?].
Topics: Antimetabolites, Antineoplastic; Cell Division; Combined Modality Therapy; Filtering Surgery; Fluorouracil; Glaucoma; Growth Inhibitors; Humans; Mitomycin; Suramin; Wound Healing | 1997 |
3 trial(s) available for suramin and fluorouracil
| Article | Year |
|---|---|
Cytotoxic chemotherapy for adrenocortical carcinoma.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bleomycin; Carcinoma; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Resistance, Multiple; Female; Fluorouracil; Gossypol; Humans; Immunologic Factors; Male; Mice; Mice, Nude; Middle Aged; Mitotane; Prospective Studies; Streptozocin; Suramin; Treatment Outcome | 1995 |
Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy. A phase II study.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Floxuridine; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Suramin; Treatment Outcome | 1995 |
Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Fluorouracil; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Suramin | 2008 |
7 other study(ies) available for suramin and fluorouracil
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
The interrelationship between the anti-mitotic action of the somatostatin analog octreotide and that of cytostatic drugs and suramin.
Topics: Animals; Antineoplastic Agents; Cell Line; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Interactions; Fluorouracil; Kinetics; Methotrexate; Mitosis; Octreotide; Pituitary Neoplasms; Prolactin; Rats; Suramin; Vincristine | 1991 |
The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Female; Fluorouracil; Humans; Male; Phosphorylcholine; Prostatic Neoplasms; Suramin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1994 |
Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Culture Media, Conditioned; Doxorubicin; Drug Resistance, Neoplasm; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Prostatic Neoplasms; Rats; Suramin; Tumor Cells, Cultured | 2000 |